Accepted at 3:46 p.m. Oct, 31, 2023
Author: Dam_Doc
Related Note: 1497314782174
Rationale for change

UWorld Step 2 Tag Added

Text
What is the preferred initial management for symptomatic patients with hypertrophic obstructive cardiomyopathy?

- First-line: {{c1::β-blockers}}
- Second-line: {{c1::Non-dihydropyridine Ca2+ channel blockers}}
Extra
- However, dihydropyridine CCBs are contraindicated

- Verapamil or disopyramide can be used as additional therapy in patients with persistent symptoms; these ↓ HR and therefore prolong diastolic filling thus decreasing outflow obstruction
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Watch Beta blockers


Watch Hypertrophic Cardiomyopathy
Sketchy 2

Watch Hypertrophic Cardiomyopathy SOAP
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Watch Class 2 Antiarrhythmics


Watch Class 4 Antiarrhythmics
Physeo
Empty field
Bootcamp
Empty field
OME

Additional Resources
One by one
Empty field
Changed Tags
#AK_Step2_v12::#UWorld::20006
#AK_Step1_v12::#FirstAid::07_Cardiovascular::04_Pathology::28_Cardiomyopathies::02_Hypertrophic_cardiomyopathy #AK_Step1_v12::#AMBOSS::B-0zzi #AK_Step2_v12::#UWorld::COMLEX::104522 #AK_Step2_v12::#UWorld::COMLEX::105240 #AK_Step2_v12::Original_decks::Dorian::im::ome::cardio::cardiomyopathy #PANCE::EOR::PEDS #AK_Step2_v12::#NBME::Form14::Section_4 #AK_Step2_v12::#OME::01_Medicine::01_Cardiology::05_Cardiomyopathy #AK_Step1_v12::#UWorld::COMLEX::27758 #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step1_v12::#Pixorize::03_Pharmacology::21_Antiarrhythmics_(New)::06_Class_II_Antiarrhythmics #AK_Step2_v12::#UWorld::Step::2686 #AK_Step2_v12::#UWorld::Step::22660 #AK_Step2_v12::Original_decks::Dorian::im::uw::cardio #AK_Step2_v12::#Resources_by_rotation::IM::uw::cardio::cardio_dorian #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::Cardio #AK_Step2_v12::#Resources_by_rotation::IM::ome::cardio::cardiomyopathy #AK_Step2_v12::#UWorld::Step::20006 #AK_Step3_v12::#UWorld::9970 #PANCE::EOR::Family_med #AK_Step3_v12::#UWorld::106125 #AK_Step2_v12::#SketchyIM::01_Cardiology::03_Cardiomyopathies_&_Heart_Muscle::03_Hypertrophic_Cardiomyopathy_SOAP !AK_UpdateTags::Step2decks::Cheesy-Dorian-(M3)::Family-Medicine::1-OME::1 #AK_Step1_v12::#Pixorize::03_Pharmacology::21_Antiarrhythmics_(New)::09_Class_IV_Antiarrhythmics #PANCE::CARDIO::cardiomyopathy #PANCE::EOR::IM #AK_Step1_v12::#B&B::05_Cardio::09_Other_Cardiovascular_Topics::06_Hypertrophic_Cardiomyopathy::Extra #AK_Step2_v12::$AnKingUpdates::$Errata::v12 #AK_Step1_v12::#UWorld::Step::22787 #AK_Step2_v12::#Subjects::Cardiology::05_Cardiomyopathy::Hypertrophic_Cardiomyopathy #AK_Step2_v12::#Subjects::Cardiology::05_Cardiomyopathy #AK_Step1_v12::#SketchyPath::01_Cardiac::03_Myocardial_&_Pericardial_Disorders::02_Hypertrophic_Cardiomyopathy #AK_Step2_v12::#AMBOSS::oD002R #AK_Step2_v12::!Shelf::IM::no_dupes::only_step2 #AK_Step1_v12::#B&B::05_Cardio::04_Arrhythmias::06_Antiarrhythmic_Drugs_I::Extra #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::#UWorld::COMLEX::28498 #AK_Step2_v12::#AMBOSS::w8ahKm #AK_Step2_v12::#Resources_by_rotation::IM::uw::cardio::cardio_zanki #AK_Step2_v12::#B&B::02_Cardio::03_Heart_Failure::03_Cardiomyopathy #AK_Step1_v12::#OME::PreClinical::Cardiac